OrthoPediatrics Future Growth
Future criteria checks 1/6
OrthoPediatrics is forecast to grow earnings and revenue by 22.6% and 16.8% per annum respectively while EPS is expected to grow by 23.1% per annum.
Key information
22.6%
Earnings growth rate
23.1%
EPS growth rate
Medical Equipment earnings growth | 17.0% |
Revenue growth rate | 16.8% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 13 Nov 2024 |
Recent future growth updates
The OrthoPediatrics Corp. (NASDAQ:KIDS) Second-Quarter Results Are Out And Analysts Have Published New Forecasts
Aug 09OrthoPediatrics Corp. (NASDAQ:KIDS) Just Reported And Analysts Have Been Lifting Their Price Targets
May 09Recent updates
Investors Still Waiting For A Pull Back In OrthoPediatrics Corp. (NASDAQ:KIDS)
Nov 05The OrthoPediatrics Corp. (NASDAQ:KIDS) Second-Quarter Results Are Out And Analysts Have Published New Forecasts
Aug 09Shareholders Should Be Pleased With OrthoPediatrics Corp.'s (NASDAQ:KIDS) Price
Aug 02OrthoPediatrics Corp. (NASDAQ:KIDS) Just Reported And Analysts Have Been Lifting Their Price Targets
May 09OrthoPediatrics (NASDAQ:KIDS) Has Debt But No Earnings; Should You Worry?
May 07Why Investors Shouldn't Be Surprised By OrthoPediatrics Corp.'s (NASDAQ:KIDS) P/S
Apr 10Why Investors Shouldn't Be Surprised By OrthoPediatrics Corp.'s (NASDAQ:KIDS) P/S
Dec 20Getting In Cheap On OrthoPediatrics Corp. (NASDAQ:KIDS) Might Be Difficult
May 05OrthoPediatrics' (NASDAQ:KIDS) Earnings Aren't As Good As They Appear
Nov 08OrthoPediatrics announces public offering of stock, pre-funded warrants
Aug 10Is OrthoPediatrics (NASDAQ:KIDS) Using Debt In A Risky Way?
Aug 08OrthoPediatrics enters distribution agreement with 3D-Side
Jul 13Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 282 | -17 | N/A | N/A | 6 |
12/31/2025 | 240 | -24 | N/A | N/A | 6 |
12/31/2024 | 203 | -29 | N/A | N/A | 6 |
9/30/2024 | 190 | -28 | -51 | -31 | N/A |
6/30/2024 | 175 | -25 | -51 | -29 | N/A |
3/31/2024 | 162 | -22 | -48 | -27 | N/A |
12/31/2023 | 149 | -21 | -46 | -27 | N/A |
9/30/2023 | 142 | -22 | -35 | -23 | N/A |
6/30/2023 | 137 | 1 | -31 | -20 | N/A |
3/31/2023 | 130 | 4 | -35 | -24 | N/A |
12/31/2022 | 122 | 1 | -32 | -22 | N/A |
9/30/2022 | 116 | 9 | -32 | -20 | N/A |
6/30/2022 | 106 | -12 | -33 | -15 | N/A |
3/31/2022 | 100 | -15 | -31 | -15 | N/A |
12/31/2021 | 98 | -16 | -30 | -13 | N/A |
9/30/2021 | 92 | -30 | -30 | -12 | N/A |
6/30/2021 | 89 | -33 | -27 | -15 | N/A |
3/31/2021 | 76 | -38 | -26 | -13 | N/A |
12/31/2020 | 71 | -33 | -30 | -19 | N/A |
9/30/2020 | 71 | -23 | -34 | -25 | N/A |
6/30/2020 | 70 | -22 | -31 | -22 | N/A |
3/31/2020 | 74 | -15 | -32 | -21 | N/A |
12/31/2019 | 73 | -13 | -30 | -18 | N/A |
9/30/2019 | 68 | -11 | -24 | -14 | N/A |
6/30/2019 | 63 | -10 | -24 | -14 | N/A |
3/31/2019 | 60 | -10 | -22 | -14 | N/A |
12/31/2018 | 58 | -12 | -21 | -16 | N/A |
9/30/2018 | 55 | -25 | -23 | -16 | N/A |
6/30/2018 | 51 | -26 | N/A | -15 | N/A |
3/31/2018 | 48 | -26 | N/A | -12 | N/A |
12/31/2017 | 46 | -24 | N/A | -7 | N/A |
9/30/2017 | 43 | -14 | N/A | -3 | N/A |
6/30/2017 | 41 | -13 | N/A | -3 | N/A |
3/31/2017 | 39 | -12 | N/A | 1 | N/A |
12/31/2016 | 37 | -12 | N/A | -1 | N/A |
3/31/2016 | 33 | -12 | N/A | -2 | N/A |
12/31/2015 | 31 | -13 | N/A | -1 | N/A |
12/31/2014 | 24 | -13 | N/A | -10 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: KIDS is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: KIDS is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: KIDS is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: KIDS's revenue (16.8% per year) is forecast to grow faster than the US market (9.1% per year).
High Growth Revenue: KIDS's revenue (16.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if KIDS's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/19 07:29 |
End of Day Share Price | 2024/12/19 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
OrthoPediatrics Corp. is covered by 9 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Michael Gorman | BTIG |
David Turkaly | JMP Securities |
Jonathan Braatz | Kansas City Capital Associates |